NIH's Budget Cuts: A Reckless Slash-and-Burn?

2025-03-02
NIH's Budget Cuts: A Reckless Slash-and-Burn?

The National Institutes of Health (NIH) recently imposed a 15% cap on indirect costs for grant recipients, sparking widespread outrage. This article refutes the policy, arguing it lacks evidentiary support and is legally flawed. The author, Leslie Bienen, contends that linking budget cuts to improved research quality is unfounded and could diminish overall research. Furthermore, the policy disproportionately harms universities, especially underfunded state institutions, ultimately jeopardizing America's global leadership in biomedical innovation. Bienen urges Congress to legally adjust funding caps, preventing this 'reckless' reform from inflicting irreparable damage on US research.

Read more
Tech biomedical

America's Healthcare System: A Total Breakdown, Beyond Insurance Companies

2024-12-14
America's Healthcare System: A Total Breakdown, Beyond Insurance Companies

The American healthcare system is broken, and the problem extends far beyond insurance companies. An oncologist argues that pharmaceutical firms, PBMs (pharmacy benefit managers), the FDA, CMS, hospitals, and doctors all share responsibility. Pharmaceutical companies push unproven drugs, PBMs profit excessively, regulators are lax, hospitals charge exorbitant fees and engage in predatory practices, and doctors order unnecessary tests and treatments. While insurance companies are frustrating, they are a scapegoat for a larger systemic issue. The author calls for sweeping reforms of the FDA and CMS to end corporate capture of regulatory agencies, addressing the high costs and inefficiency of the US healthcare system. The recent assassination of an insurance CEO highlights public frustration with the system.

Read more